Status:
COMPLETED
Web Based Tools to Improve Medication Continuity in Adolescents With ADHD
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Attention Deficit Hyperactivity Disorder
Adherence, Medication
Eligibility:
All Genders
11-15 years
Phase:
NA
Brief Summary
Medication is an efficacious treatment strategy for adolescents with attention-deficit/hyperactivity disorder (ADHD), however use significantly declines during adolescence when the consequences of ADH...
Eligibility Criteria
Inclusion
- First prescribed ADHD medicine more than one year prior to enrollment
- Treated by pediatrician at practice participating in study
- Filled at least one prescription for a stimulant medication in the past year
Exclusion
- More than 80% of days covered with medicine over past one year
- Poor understanding level: The participant and parent cannot understand or follow instructions given in the study.
- Do not have reliable access to the internet at their home or another location.
- Parent will not permit their child to access the internet for study related activities
- Are not able or willing to send or receive text messages for study related activities
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 24 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04386096
Start Date
June 1 2020
End Date
May 24 2021
Last Update
March 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229-3039